GPCR Congress

9-10 June 2010, Le Montreux Palace, Montreux, Switzerland

Home

Co-located Drug Discovery Summit

GPCR Congress is administered by Osney Media.

Speakers

Our carefully researched speaker programmes are further enhanced by the opportunity for the delegates and speakers to discuss topics of interest in more detail during panel and round table discussions. This means that the attendees not only benefit from the expertise of the high level speaker panel but also that of the other delgates.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Mike Burden at m.burden@oxfordglobal.co.uk







	Prof. Ross Bathgate, Leader Neuropeptides Division, Florey Neuroscience Institutes, University of Melbourne, Australia

	Caterina Bissantz, Chemistry technologies and Innovation, F.Hoffman La Roche

	Paola Casarosa, Lab head, Post Development R&D Bronchodilators, Boehringer-Ingelheim Pharma

	Rafael Franco, Professor, Department of Biochemistry and Molecular Biology, University of Barcelona

	Steve Garland, Group Leader Lead Generation GSK

	David Gloriam, Department of Medicinal Chemistry, Copenhagen University

	Danilo Guerini, Department of BioChemistry, Novartis

	Mike Hanson, Associate Director Structural Biology, Receptos

	Robert Lane, Post Docutoral Fellow, Faculty of Science, Leiden/Amsterdam Center for Drug Research, Medicinal Chemistry, Univeristy of Leiden

	Jonathon Mason, Head of Computational Chemistry, Heptares Therapeutics, UK & Chief Scientist, Medicinal Chemistry, Lundbeck Research, DK

	Jean Mazella, Lab Head, Institut de Pharmacologie Moleculaire et Cellulaire CNRS, University of Nice-Sophia Antipolis, France

	Wim Meutermans, VP Discovery, Alchemia

	Graeme Milligan, Professor or Molecular Pharmacology; Joint Research Director, Faculy of Biomedical and Life Sciences, University of Glasgow

	Florian M�llershausen, Laboratory Head Developmental & Molecular Pathways, Novartis

	Kevin Pfleger, Research Associate Professor, Head of the Laboratory for Molecular Endocrinology - GPCRs, Western Australian Institute for Medical Research and Centre for Medical Researcg, University of Western Australia

	Zara Sands, Computational Medicinal Chemist, UCB

	Chris van Koppen, Team Lead, Molecular Pharmacology, Merck Research Laboratories

	Ulrich Wendt, Director Structural Biology, Sanofi-Aventis

	Mike Wood, Associate Director, Vanderbilt Program in Drug Discovery, Vanderbilt University Medical Center

	Keith Wreggett, Target Biology, Bioscience, AstraZeneca